Tibor Bakacs (T Bakacs)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 7

Top Topics

Advanced Cancer

Peritoneal Dialysis

Prognostic Factors

Top Venues

JCO precision oncology

Hepatology, medicine and policy

Cancer immunology, immunotherapy : CII

Scandinavian journal of immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Csaba Kerepesi, Hassan Mohammed Abushukair, Biagio Ricciuti, Amin H Nassar, Elio Adib, Joao M Victor Alessi, Federica Pecci, Mehrdad Rakaee, Muhammad Zaki Hidayatullah Fadlullah, Anna-Mária Tőkés, Scott J Rodig, Mark M Awad, Aik Choon Tan, Tibor Bakacs, Abdul Rafeh Naqash
Association of Baseline Tumor-Specific Neoantigens and CD8 + T-Cell Infiltration With Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors. JCO precision oncology 8 (2024)
Csaba Kerepesi, Hassan Mohammed Abushukair, Biagio Ricciuti, Amin H Nassar, Elio Adib, Joao M Victor Alessi, Federica Pecci, Mehrdad Rakaee, Muhammad Zaki Hidayatullah Fadlullah, Anna-Mária Tőkés, Scott J Rodig, Mark M Awad, Aik Choon Tan, Tibor Bakacs, Abdul Rafeh Naqash
Association of Baseline Tumor-Specific Neoantigens and CD8 + T-Cell Infiltration With Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors. JCO precision oncology 8 (2024)
Csaba Kerepesi, Hassan Mohammed Abushukair, Biagio Ricciuti, Amin H Nassar, Elio Adib, Joao M Victor Alessi, Federica Pecci, Mehrdad Rakaee, Muhammad Zaki Hidayatullah Fadlullah, Anna-Mária Tőkés, Scott J Rodig, Mark M Awad, Aik Choon Tan, Tibor Bakacs, Abdul Rafeh Naqash
Association of Baseline Tumor-Specific Neoantigens and CD8 + T-Cell Infiltration With Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors. JCO precision oncology 8 (2024)
Tibor Bakacs, Volker Sandig, Imre Kovesdi
Combination Therapy for the Treatment of Shingles with an Immunostimulatory Vaccine Virus and Acyclovir. Pharmaceuticals (Basel, Switzerland) 16 (2) (2023)
R Kleef, R Nagy, A Baierl, V Bacher, H Bojar, D L McKee, R Moss, N H Thoennissen, M Szász, Tibor Bakacs
Low-dose ipilimumab plus nivolumab combined with IL-2 and hyperthermia in cancer patients with advanced disease: exploratory findings of a case series of 131 stage IV cancers - a retrospective study of a single institution. Cancer immunology, immunotherapy : CII 70 (5) (2020)
Tibor Bakacs, Ralph W Moss, Ralf Kleef, Marcell A Szasz, Colin C Anderson
Exploiting autoimmunity unleashed by low-dose immune checkpoint blockade to treat advanced cancer. Scandinavian journal of immunology 90 (6) (2019)
Tibor Bakacs, Rifaat Safadi, Imre Kovesdi
Post-infection viral superinfection technology could treat HBV and HCV patients with unmet needs. Hepatology, medicine and policy 3 (2018)